PharmaCielo Ltd. (OTCMKTS:PCLOF) Short Interest Down 39.2% in April

by · The Cerbat Gem

PharmaCielo Ltd. (OTCMKTS:PCLOF – Get Free Report) was the recipient of a significant decline in short interest in April. As of April 30th, there was short interest totaling 52,246 shares, a decline of 39.2% from the April 15th total of 85,990 shares. Based on an average trading volume of 215,929 shares, the short-interest ratio is currently 0.2 days.

PharmaCielo Stock Up 12.7%

OTCMKTS:PCLOF traded up $0.01 during midday trading on Tuesday, hitting $0.07. The stock had a trading volume of 20,000 shares, compared to its average volume of 69,618. The stock has a 50-day moving average of $0.04 and a 200 day moving average of $0.04. PharmaCielo has a one year low of $0.00 and a one year high of $0.12.

PharmaCielo Company Profile

(Get Free Report)

PharmaCielo (OTCMKTS:PCLOF) is a Colombia-based, vertically integrated cannabinoid extraction and manufacturing company that develops pharmaceutical-grade active ingredients for the global medical cannabis market. The company specializes in the cultivation, extraction, purification and isolation of cannabinoids, producing a range of high-purity oils, distillates and isolates that serve as the active pharmaceutical ingredients (APIs) in end-use formulations. PharmaCielo’s product portfolio is designed to meet Good Manufacturing Practices (GMP) standards, enabling partnerships with pharmaceutical firms and wellness brands seeking compliant, consistently standardized cannabinoid inputs.

Since commencing operations, PharmaCielo has established a state-of-the-art extraction facility in Colombia, leveraging the country’s favorable agronomic conditions and regulatory framework for medicinal cannabis cultivation.

See Also